Polymeric prodrugs conjugated with reduction-sensitive dextran–camptothecin and pH-responsive dextran–doxorubicin: an effective combinatorial drug delivery platform for cancer therapy-Reference-Cited by-同舟云学术

Polymeric prodrugs conjugated with reduction-sensitive dextran–camptothecin and pH-responsive dextran–doxorubicin: an effective combinatorial drug delivery platform for cancer therapy

Published:2016 Issue:25 Volume:7 Page:4198-4212
ISSN:1759-9954
Container-title:Polymer Chemistry
language:en
Short-container-title:Polym. Chem.

Author:

Cao Dongling¹²³⁴⁵,He Jinlin¹²³⁴⁵,Xu Jiaying⁶⁷⁸⁹¹⁰,Zhang Mingzu¹²³⁴⁵,Zhao Lin⁶⁷⁸⁹¹⁰,Duan Guangxin⁶⁷⁸⁹¹⁰,Cao Youwen¹²³⁴⁵,Zhou Ruhong⁶⁷⁸⁹¹⁰,Ni Peihong¹²³⁴⁵

Affiliation:

1. College of Chemistry

2. Chemical Engineering and Materials Science

3. State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials

4. Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis

5. Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application

6. School for Radiological & Interdisciplinary Science

7. and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions

8. Soochow University

9. Suzhou 215123

10. P. R. China

Abstract

Two types of stimuli-sensitive polymeric prodrugs for combinatorial cancer therapy have been prepared and found to exhibit favorable anticancer activity in vitro and in vivo.

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Polymers and Plastics,Biochemistry,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2016/PY/C6PY00701E

Reference70 articles.

1. Anticancer therapeutics: “Addictive” targets, multi-targeted drugs, new drug combinations

2. Optimizing Combination Chemotherapy by Controlling Drug Ratios

3. Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines

4. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

5. Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative Fluorescent Polymers in Niosomal Carriers: A Novel Approach to Enhancing Cancer Therapy and Imaging;Macromolecular Bioscience;2024-09-02

2. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy;Acta Biomaterialia;2024-04

3. Polymers in advanced drug and gene delivery;Polymers for Pharmaceutical and Biomedical Applications;2024

4. Stimulus‐Responsive Nano‐Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery;Small Methods;2023-12-12

5. Reversible Cross-linked Thermoresponsive Polycaprolactone Micelles for Enhanced Stability and Controlled Release;Biomacromolecules;2023-11-14